Call for Abstracts
Congress Format
We plan to hold the event in person. All presentations will be delivered on-site, and we do not plan to offer live streaming or on-demand streaming. If there are any changes in the future, we will provide updates on our website.
Abstract Submission Guidelines
- Abstracts will be accepted through online registration using the UMIN system.
- The name of the presenting author and the abstract title must be entered in
both Japanese and English if submitted in Japanese. - Although the presentation can be in Japanese, the abstract text can be written
in either Japanese or English (English abstracts are recommended). - General abstracts (Oral presentations: English) are also being widely solicited. We welcome submissions for presentations in English. Participants studying in Japan will have their registration fees waived.
- In general, the first author is the presenter.
- For sessions with international speakers, please register an English abstract.
- The registration number and password issued at the time of abstract submission are required for confirmation of receipt and for making corrections, so please be sure to keep a record of them.
- Please read the important notes carefully, and then proceed to the abstract submission page by clicking the button at the bottom of this page.
- Supported Browsers: Firefox, Google Chrome, Microsoft Edge and Safari.
Abstract Submission Categories
Oral presentations in Japanese, |
Open Call |
|---|---|
| Invited Abstracts (excluding General Presentation and Symposium) |
By Invitation Only Note: Only those specifically invited can submit. Submissions from others will be invalid. |
Abstract Submission Period
- General Abstracts & Symposium:
From Tuesday, March 4, at noon – Tuesday, April 15, 2025, at noon (JST) - Invited Abstracts:
Notification will be sent individually to the invited presenters.
Presentation Format
General presentation, Symposiums, Workshops
For general presentation, symposiums, and workshops, please select your preferred presentation format (oral presentation, poster, symposium/workshop) during the registration process.
However, please note that we may not be able to accommodate all preferences.
The acceptance and presentation format decisions will be made by the program committee. After abstract review, notifications regarding acceptance, presentation format, abstract number, etc., will be sent via email (expected to be in late June 2025).
Invited Topics
Please select the requested session.
If you require any special accommodation on the day of the presentation (e.g., wheelchair access), please indicate this on the registration page and inform the secretariat.
Ethical Standards (Important)
It is a requirement for submission that the research does not involve any ethical issues. The presenter will bear ethical responsibility when presenting. When registering the abstract, please comply with the "Ethical Considerations for Abstract Submission at the Annual Meeting" established by the Japan Epilepsy Society and answer the questions on the abstract registration page accordingly.
For more details, please refer to the following link.
Awards
1. Best Poster Award
| Overview | Outstanding abstracts from the general poster presentations will be selected for each category (Psychiatry, Neurology, Pediatrics, Neurosurgery, Basic Research, and Co-medical). |
|---|---|
| Eligibility | The first author must be under 40 years old as of April 1, 2025. |
| Application | Self-declaration and application are required at the time of abstract submission. |
2. YES-Japan Excellent Presentation Award
(YES-Japan Award)
| Overview | Outstanding abstracts from general poster presentations will be recognized. |
|---|---|
| Eligibility | The first author must be under 40 years old and belong to one of the following categories:
|
3. YES-Japan English Session Excellent Presentation Award
(YES-Japan English Session Award)
| Overview | Outstanding abstracts from both oral and poster presentations will be recognized. |
|---|---|
| Eligibility | The first author must be under 40 years old and belong to one of the following categories:
|
Additional Information
The abstract for the YES-Japan English session can be the same as the general abstract. However, an English abstract must be submitted in Word format to the conference office at jes58@convex.co.jp.
4. Awards (1, 2, 3 Common)
Award Ceremony
The awards are scheduled to be presented at the closing ceremony of the congress.
Eligibility and Conditions
The first author of the general abstract is considered the presenter. Furthermore, the first author must be a regular or temporary member of the Japan Epilepsy Society.
Non-members must contact the society office and complete the membership process (either regular or temporary) at the time of abstract submission.
If a temporary member is the first author, at least one of the co-authors must be a regular member.
Membership Procedure
The Japan Epilepsy Society Office
URL：http://square.umin.ac.jp/jes/gaiyo/entrance-guide.html
E-mail：jes-oas@umin.ac.jp
TEL・FAX：+81-42-345-2522
Cautions for Inputting Registration Details
Session Selection
You need to choose between the following options for your presentation type:
Select Your Presentation Type
Oral Presentation, Poster Presentation, Symposium/Workshop
| 1 | Oral Presentation: Choose this option if you will be presenting orally, either in Japanese or English. |
|---|---|
| 2 | Poster Presentation: If you prefer a poster presentation, select this option, again with either Japanese or English. |
| 3 | Symposium/Workshop: If you’re presenting as part of a symposium or workshop, select this option and indicate your preferred language for the oral presentation (Japanese or English). |
Specified Topics
| 1 | Educational Lecture |
|---|---|
| 2 | Special Lecture |
| 3 | Committee-Planned Lecture |
| 4 | Others |
Maximum Number of Authors Allowed for Registration
First author + co-authors: 15 people
Maximum Number of Affiliated Institutions Allowed for Registration
15 institutions
Category Selection
Category Selection 1 (General Presentations)
Please select the categories from the following list, indicating your 1st and 2nd choices for presentation format (Oral or Poster):
| 01 | Etiology/Epidemiology |
|---|---|
| 02 | Underlying Condition/Disease |
| 03 | Classification/Syndrome |
| 04 | Genetics |
| 05 | Ictal Semiology |
| 06 | EEG/MEG/Neurophysiology |
| 07 | Neuroimaging |
| 08 | Medication |
| 09 | Surgery |
| 10 | Other Treatment |
| 11 | Clinical Course/Prognosis |
| 12 | Social Aspect/QOL |
| 13 | Comorbidity |
| 14 | Psychiatric Symptom |
| 15 | Development/Neuropsychology |
| 16 | Comprehensive/Integrated Care |
| 17 | Medical System |
| 18 | Medical Staff Session |
| 19 | Adverse Effect |
| 20 | Pharmacology |
| 21 | Physiology |
| 22 | Pathology |
| 23 | Biochemistry |
| 24 | Neurotransmitter |
| 25 | Experimental Epilepsy |
| 26 | Case Report |
| 27 | Art, History |
Category Selection 2 (Symposium and Workshop)
Please select the categories from the following list for presentation format (Symposium or Workshop):
| 01 | Rapid Changes in Epilepsy Care, Research, and Social Implementation: Current Status and Near-Future Outlook |
|---|---|
| 02 | Achieving 90%, 80%, and 70% of IGAP Goals |
| 03 | Interim Report on Epilepsy Clinical Practice Guidelines |
| 04 | Epilepsy Care Networks |
| 05 | Collaborative Care in Regions Without Epilepsy Centers (Series) |
| 06 | Women and Epilepsy |
| 07 | Industry-Academia Collaboration in Epilepsy |
| 08 | A Message to Your Medical Department! |
| 09 | Rare Epilepsy Syndrome Research Project |
| 10 | Rescue Medications Usable Outside Hospitals |
| 11 | Epilepsy Associated with Tuberous Sclerosis (in Conjunction with the Guideline Publication) |
| 12 | Lifelong Epilepsy Care: Pursuing True Long-Term Comprehensive Epilepsy Medicine |
| 13 | Epilepsy and Neuroinflammation |
| 14 | Epilepsy, Dementia, and Stroke: Considering the Disease Triangle |
| 15 | Epileptogenicity Evaluation by Electrical Stimulation: Current Status and Future Outlook |
| 16 | SEEG: Champion Cases and Problem Cases |
| 17 | Epilepsy Surgery: The Clinical Significance of Non-Invasive Examinations |
| 18 | The Future of Pediatric Epilepsy Surgery |
| 19 | Insular Epilepsy and Cingulate Epilepsy |
| 20 | VNS 15th Anniversary Project: The Present and Future of VNS |
| 21 | The Role of Psychologists in Epilepsy Care |
| 22 | Epilepsy and Stigma |
| 23 | Medical Cannabis in the Era of the Narcotics and Psychotropics Control Act |
Abstract Words Count
For General Presentation, Symposium and Workshop
(for both Japanese and English Oral and Poster Presentations)
Title
- Full width (Japanese): up to 50 characters
- Half width (English): up to 25 words
Abstract (body text)
- Full width (Japanese): up to 800 characters
- Half width (English): up to 220 words
Total Words Count including
(Author, affiliation, title and abstract text)
- Full width (Japanese): up to 1,100 characters
- Half width (English): up to 300 words
Excluding General Presentation, Symposium and Workshop
(for designated presentations)
Title
- Full width (Japanese): up to 50 characters
- Half width (English): up to 25 words
Abstract (body text)
- Full width (Japanese): up to 1,200 characters
- Full width (English): up to 350 words
Total Words Count including
(Author, affiliation, title and abstract text)
- Full width (Japanese) up to 1,500 characters
- Half width (English) up to 450 words
The abstract body text should be divided into the following sections
- Objective
- Target and Methods
- Results
- Conclusion
Disclosure of Conflicts of Interest (COI)
- In order to appropriately promote clinical research through industry-academia collaboration and to ensure the scientific and ethical integrity of the research results, all presenters are required to disclose any conflicts of interest (COI) to ensure neutrality and transparency in the presentation of clinical research findings.
- Please answer the "Conflict of Interest (COI)" questions in the system at the time of abstract submission.
- For the detailed information on the Policy on Conflicts of Interest (COI) in Clinical Research, click here.
- Please contact the Secretariat of the Japan Epilepsy Society (see below) for any technical questions on COI.
COI Disclosure Form (Template)
for Oral and Poster Presentations at the annual congress.
Secretariat of the Japan Epilepsy Society
https://square.umin.ac.jp/jes/index.html
4-6-15 Ogawahigashi-cho, Kodaira City, Tokyo, 187-0031, Japan
E-mail：jes-oas@umin.ac.jp
TEL and FAX：+81-42-345-2522
Abstract Submission
New Submission
Review/Modify (Add) or Withdraw
